Dyne Therapeutics, Inc. · BX:DYN
Dyne Therapeutics, Inc. shareholders
As of Sep 30, 2026, 259 institutions reported holding Dyne Therapeutics, Inc. Largest: T. Rowe Price, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
Shareholders
Institutions
| Holder | Shares | Value | Change vs Jun 30 | Filed |
|---|---|---|---|---|
| T. Rowe Price | 38M | US$612M | +3.15M | Nov 16, 2026 |
| BlackRock | 14.5M | US$233M | +2.07M | Nov 13, 2026 |
| Vanguard | 13.7M | US$221M | +2.18M | Nov 13, 2026 |
| Janus Henderson | 12M | US$194M | First report | Nov 16, 2026 |
| Fidelity | 11.1M | US$180M | −60,631 | Nov 10, 2026 |
| Wellington | 10.6M | US$170M | +10.5M | Nov 16, 2026 |
| State Street | 8.16M | US$131M | +700K | Nov 12, 2026 |
| Orbis Allan Gray Ltd | 7.33M | US$118M | +327K | Nov 16, 2026 |
| Vestal Point Capital, LP | 6.2M | US$99.9M | +2.83M | Nov 16, 2026 |
| TCG Crossover Management, LLC | 4.62M | US$74.3M | No change | Nov 16, 2026 |
| Geode Capital | 4.4M | US$70.8M | +653K | Nov 6, 2026 |
| Frazier Life Sciences Management, L.P. | 3.85M | US$62.1M | +700K | Nov 16, 2026 |
| Fcpm III Services B.V. | 3.59M | US$57.8M | −261K | Nov 16, 2026 |
| Atlas Venture Life Science Advisors, LLC | 3.44M | US$55.4M | −3.36M | Nov 10, 2026 |
| Mpm Bioimpact LLC | 3.21M | US$51.7M | +1.29M | Nov 16, 2026 |
| Logos Global Management LP | 3M | US$48.3M | +450K | Nov 19, 2026 |
| JPMorgan | 2.91M | US$47.4M | −239K | Nov 12, 2026 |
| Armistice Capital, LLC | 2.68M | US$43.1M | −409K | Nov 16, 2026 |
| Bank of America | 2.56M | US$41.2M | +322K | Nov 16, 2026 |
| Sofinnova Investments, Inc. | 2.51M | US$40.5M | +853K | Nov 16, 2026 |
| Siren, L.L.C. | 2.43M | US$39.1M | +300K | Nov 12, 2026 |
| Franklin Templeton | 2.39M | US$43.4M | −51,186 | Nov 12, 2026 |
| Polar Capital Holdings Plc | 2.27M | US$36.6M | +985K | Nov 16, 2026 |
| Venrock Adviser, LLC | 2.17M | US$35M | No change | Nov 16, 2026 |
| Goldman Sachs | 2.06M | US$33.2M | −93,654 | Nov 16, 2026 |
| Dimensional | 1.98M | US$32M | +37,036 | Nov 4, 2026 |
| Citadel | 1.95M | US$31.5M | +811K | Nov 16, 2026 |
| Samlyn Capital, LLC | 1.93M | US$31.1M | +176K | Nov 16, 2026 |
| Bain Capital Life Sciences Investors, LLC | 1.9M | US$30.6M | New | Nov 16, 2026 |
| Palo Alto Investors LP | 1.88M | US$30.3M | +234K | Nov 16, 2026 |
| Schwab | 1.59M | US$25.6M | +388K | Nov 16, 2026 |
| Northern Trust | 1.47M | US$23.7M | +195K | Nov 16, 2026 |
| Fiera Capital Corp | 1.44M | US$23.1M | +645K | Nov 6, 2026 |
| Novo Holdings A/S | 1.38M | US$22.2M | +416K | Nov 16, 2026 |
| abrdn | 1.35M | US$21.8M | −186K | Nov 10, 2026 |
| Perceptive Advisors LLC | 1.27M | US$20.4M | −1.42M | Nov 16, 2026 |
| Balyasny Asset Management L.P. | 1.19M | US$19.1M | New | Nov 16, 2026 |
| Morgan Stanley | 1.17M | US$18.9M | +424K | Nov 13, 2026 |
| UBS | 987K | US$15.9M | +274K | Nov 16, 2026 |
| Rock Springs Capital Management LP | 892K | US$14.4M | −50,285 | Nov 16, 2026 |
| Saturn V Capital Management LP | 837K | US$13.5M | −220K | Nov 16, 2026 |
| Baker Bros. Advisors LP | 813K | US$13.1M | No change | Nov 16, 2026 |
| BNY | 776K | US$12.5M | +367K | Nov 5, 2026 |
| Marshall Wace, LLP | 687K | US$11.1M | −802K | Nov 13, 2026 |
| Ghisallo Capital Management LLC | 650K | US$10.5M | New | Nov 19, 2026 |
| TD | 612K | US$9.93M | +64,268 | Nov 13, 2026 |
| Raymond James Financial Inc | 544K | US$8.77M | −32,162 | Nov 12, 2026 |
| Vivo Capital, LLC | 514K | US$8.29M | −1.04M | Nov 13, 2026 |
| Tetragon Partners GP Ltd | 511K | US$8.24M | +155K | Nov 16, 2026 |
| ExodusPoint Capital Management, LP | 494K | US$7.96M | New | Nov 16, 2026 |
This page holds 50 of 259 holders.
Funds
This page holds 50 of 234 holders.
Big stakes
| Holder | Stake | Shares | Date |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 18.70% | 30.8M | Mar 31, 2026 |
| Janus Henderson Group PLC | 7.30% | 12M | Jun 30, 2026 |
| BlackRock, Inc. | 7.00% | 11.5M | Jun 30, 2026 |
| FMR LLC | 6.80% | 11.2M | Jun 30, 2026 |
| Wellington Management Group LLP | 5.70% | 10.6M | Sep 30, 2026 |